US FDA plans public workshop on evaluating medtech, pharma countermeasures for children
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration is to host a public workshop on the ethical and regulatory challenges associated with evaluating whether medical countermeasures developed to deal with public health emergencies are safe and effective in the paediatric population.